JNJ

NYSE

Johnson & Johnson

$255.70

Healthcare · Drug Manufacturers - General

JNJ Key Statistics

Market Cap

$615.79B

P/E Ratio

29.51

EPS (TTM)

8.60

52-Week High

$256.54

52-Week Low

$151.52

Analyst Target

$265.43

About Johnson & Johnson

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Get the full AI-powered analysis for JNJ

Sign in to unlock AI trade strategies, entry/exit timing in US Eastern Time, ROI projections, technical indicators (RSI, MACD, Bollinger Bands), earnings forecasts, and Sharia compliance screening.

Get Started Free

Other Popular US Stocks

Disclaimer: This application does not guarantee investment results. Use at your own risk. The information provided is for educational purposes only and should not be considered as financial advice.